During this program, which took place on June 27, 2013, engineers from MIT and the Koch Institute presented new technologies for cancer diagnosis and drug development. The aim of the session was to stimulate new collaborations between MIT and the Koch Institute scientists and engineers with DF/HCC members, in preparation for the 2014 round of Bridge funding.
Speakers and Presentations
Opening Remarks
|
|
David LivingstonDeputy Director of the DF/HCC. Emil Frei Professor of Medicine, Department of Medicine, and Professor, Department of Genetics, Harvard Medical School. Chairman, Executive Committee for Research, Dana-Farber Cancer Institute |
Early Detection/Diagnostics
|
|
Barbara ImperialiClass of 1922 Professor of Chemistry and Professor of Biology, MIT |
|
|
Peter SoProfessor of Mechanical Engineering, and Biological Engineering, MIT |
 |
Joel VoldmanAssociate Professor of Electrical Engineering and Computer Science, MIT |
|
|
Krystyn van VlietPaul M. Cook Career Development Associate Professor of Materials Science and Engineering, MIT |
Systems Biology
 |
Doug LauffenburgerMember of the Koch Institute and Ford Professor of Biological Engineering, Chemical Engineering, and Biology, MIT. Head of the Department of Biological Engineering, MIT |
 |
Ron WeissAssociate Professor of Biological Engineering, MIT |